Published: August 03, 2011
IntegenX and Promega Ink RapidHIT Human Identification System Reagent Supply Agreement
PLEASANTON, Calif. & MADISON, Wis. - (BUSINESS WIRE) - IntegenX Inc. and Promega Corporation today announced that commercial
deliveries of RapidHIT 200 Human Identification Systems will include
Promega's nucleic acid purification and short tandem repeat (STR)
amplification reagents. Promega's established STR chemistry will enable
users of the automated, self-contained RapidHIT System to produce DNA
profiles for human identification from mouth swabs and other human
samples in less than two hours.
IntegenX RapidHIT(TM) 200 will be used in conjunction with Promega purification and STR chemistry to deliver rapid DNA testing (Photo: Business Wire)
Promega's purification and STR reagents will be packaged with the
RapidHIT System's disposable cartridges, which will automate all DNA
sample processing steps required to generate DNA profiles, including
cell lysis, DNA purification, STR amplification, separation and
detection of amplified products, and data analysis. The single-use
cartridges eliminate the need for user intervention during sample
processing, greatly simplifying the process of human DNA profile
production and eliminating the risk of sample carryover. By integrating
Promega's purification and STR reagents, RapidHIT Systems can produce
DNA profiles compatible with local, national, and international database
systems, including the U.S. National DNA Index System (NDIS), the U.K.
National DNA Database (NDNAD), and Local DNA Index System (LODIS)
systems used by local law enforcement agencies.
"The RapidHIT Human Identification System represents a highly automated
and specialized integration of our STR amplification chemistry," said
Bill Linton, Chairman and Chief Executive Officer of Promega
Corporation. "The supply agreement with IntegenX gives law enforcement
agencies and other organizations the choice to adopt powerful DNA-based
human identification technology without adding the specialized
infrastructure that's usually required for a DNA lab," added Mr. Linton.
"Promega has been a great partner that we have worked with to optimize
the use of their STR chemistry in our RapidHIT 200 system," said Stevan
Jovanovich, President and Chief Executive Officer of IntegenX Inc. "The
combination of IntegenX's technology and Promega's chemistry will help
make the RapidHIT 200 the platform of choice for rapid human DNA
identification."
IntegenX will commence commercial shipments of the RapidHIT 200 Human
Identification System in early 2012. A limited number of pre-production
RapidHIT systems are presently available to Early Access Program partners
About IntegenX
IntegenX Inc. (IXI), headquartered in Pleasanton, CA, is a
privately-held company that designs, manufactures, and markets solutions
for DNA and RNA sample preparation laboratory workflows. IntegenX's
products eliminate the most acute pain points affecting researchers,
laboratory workers and field based personnel. IntegenX's microfluidics
technology platforms integrate advanced fluidics and robotic
capabilities to prepare samples for DNA and RNA sequencing and to
produce sample-to-answer performance for DNA-based forensics and human
identity (HID) testing, next generation sequencing, biodefense, and
molecular diagnostics applications. For more information, please visit www.integenx.com.
About Promega
Promega Corporation has provided products for DNA-based human
identification for over 20 years. Promega Corporation is a leader in
providing innovative solutions and technical support to the life
sciences industry. The company's 2,000 products enable scientists
worldwide to advance their knowledge in genomics, proteomics, cellular
analysis, molecular diagnostics and human identification. Founded in
1978, the company is headquartered in Madison, WI, USA with branches in
15 countries and over 50 global distributors. For more information about
Promega, visit www.promega.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6817836&lang=en

IntegenX Inc.
Howard D. Goldstein, (925) 701-3400
Executive
Vice President, Commercial Affairs
howardg@integenX.com
or
Promega
Corporation
Penny Patterson, (608) 274-4330
Director,
Corporate Affairs
penny.patterson@promega.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News